Earnings Release • Nov 15, 2012
Earnings Release
Open in ViewerOpens in native device viewer
News Details
Corporate | 15 November 2012 09:42
MPH Mittelständische Pharma Holding AG: MPH achieved a strong growth in sales and earnings in the first nine month 2012
MPH Mittelständische Pharma Holding AG / Key word(s): Quarter Results
15.11.2012 / 09:42
MPH Mittelständische Pharma Holding AG:
MPH achieved a strong growth in sales and earnings in the first nine month 2012
For the first nine months of the current year, the Group is reporting sales of EUR 158.47 million, with thus representing an increase of 48 % compared to the same period of the previous year (prior-year period: EUR 106.98 million). The consolidated profit after taxes for January through September 2012, at EUR 15.57 million, was 95 % above the prior-year level (EUR 7.96 million).
In the third quarter of 2012 MPH Mittelständische Pharma Holding AG continued its strong performance recorded in the first half of the year. For the period from July to September of the current year, the Group generated sales of Euro 59.18 million and thus a growth of 61 % (prior-year period: EUR 36.63 million). In the third quarter the Group profit after taxes of EUR 5.84 million, with growth of 99 % compared to the same period of the previous year (EUR 3,10 million) could almost be doubled.
Growth was mainly driven by developing sales markets, new product approvals, in particular in the oncological field and the integration of new Healthcare activities. As well as in the first half of 2012 the new Healthcare activities made a significant contribution to the overall profitability of the group. The Healthcare segment is not subject to the German Compulsory Discount and is now to be expanded even further.
The development of the first nine month demonstrates that the strategy of MPH AG works. For the full year 2012 the Managing Board is confirming its expectations to increase sales to at least EUR 188 million. The company thus continues the dynamic business development of the last years.
About MPH Mittelständische Pharma Holding AG:
The company MPH Mittelständische Pharma Holding AG, based in Berlin, has strategically concentrated its activities on growth segments Pharma and Healthcare. On the basis of patent-free and patent-protected active substances, production and consultancy services for therapies of chronic diseases, the Group makes a precious contribution to keeping health affordable.
MPH Mittelständische Pharma Holding AG is listed in the Entry Standard (Open Market) of the Frankfurt stock exchange.
Key figures for the share of MPH Mittelständische Pharma Holding AG:
Subscribed capital: EUR 41.167.155
Listed shares: Preference shares
Number of preference shares in circulation: 19.025.000
ISIN: DE000A0NF697
WKN: A0NF69
Stock symbol: 93MV
Contact:
Linda Reichelt
MPH Mittelständische Pharma Holding AG
Hubertusallee 73
D-14193 Berlin
Tel:+49 (0) 30 897308660 Fax:+49 (0) 30 897308670
E-Mail: [email protected] Web: www.mph-ag.de
End of Corporate News
15.11.2012 Dissemination of a Corporate News, transmitted by DGAP – a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
| Language: | English |
| Company: | MPH Mittelständische Pharma Holding AG |
| Hubertusallee 73 | |
| 14193 Berlin | |
| Germany | |
| Phone: | 030 / 897 308 660 |
| Fax: | 030 / 897 308 670 |
| E-mail: | [email protected] |
| Internet: | www.mph-ag.de |
| ISIN: | DE000A0NF697 |
| WKN: | A0NF69 |
| Listed: | Freiverkehr in Berlin, Düsseldorf, Stuttgart; Open Market (Entry Standard) in Frankfurt |
| End of News | DGAP News-Service |
| - - - |
| 193345 15.11.2012 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.